« International Phase III Study Revealed That XELOX (Xeloda® + oxaliplatin) Equals FOLFOX in Overall Patient Survival From Advanced Colorectal Cancer | Main | Bioponic Phytoceuticals’ Curecumin™ Product Potentially Effective Against Alzheimer's Disease (AD) »

Jan23
Cell Genesys, Inc.’s GVAX® Immunotherapy Passed Follow-Up Phase 2 Clinical Trial for Pancreatic Cancer
Follow-up data from a Phase 2 clinical trial of Cell Genesys, Inc. (Nasdaq: CEGE)’s GVAX® immunotherapy for pancreatic cancer in 60 patients with operable pancreatic cancer who received the immunotherapy after surgical resection of their tumor and adjuvant radiation and chemotherapy, revealed encouraging results.
The updated results showed a median survival of 26.8 months. This compares favorably with published, historical data from multiple single-arm and randomized studies in patients undergoing pancreatic cancer surgery and adjuvant therapy for whom the median survival has been reported to be in the range of 17 to 22 months, including the most recently reported results for gemcitabine chemotherapy.

prostate_gland.jpgThe study, conducted by Johns Hopkins Kimmel Cancer Center was designed to evaluate the safety and efficacy of GVAX® immunotherapy for pancreatic cancer which is a non patient-specific immunotherapy being developed as an "off-the-shelf" pharmaceutical product.

Details of the clinical data were presented by Daniel Laheru, M.D., assistant professor of medical oncology at Johns Hopkins Kimmel Cancer Center, and colleagues, at the recent 2007 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida.

Read the full report at Cell Genesys, Inc.

[Photo Credit: MedicineNet]


0 Comments/Trackbacks




submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« International Phase III Study Revealed That XELOX (Xeloda® + oxaliplatin) Equals FOLFOX in Overall Patient Survival From Advanced Colorectal Cancer | Main | Bioponic Phytoceuticals’ Curecumin™ Product Potentially Effective Against Alzheimer's Disease (AD) »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb